ONO-8025 Phase II Study

ONO-8025 Phase II Study -A Multicenter Randomized Double-blind Study in Chronic Obstructive Pulmonary Disease (COPD) Patients-

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221718

Enrollment

Registered

2012-02-24

Start date

2012-02-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

investigational material(s) Generic name etc : ONO-8025 INN of investigational material : imidafenacin Therapeutic category code : 225 Bronchodilators Dosage and Administration for Investigational mat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients with GOLD stage II or III COPD

Exclusion criteria

Exclusion criteria: 1.Presence or history of bronchial asthma, or presence of lung cancer, bronchiectasis, diffuse panbronchiolitis, sinoatrial syndrome, interstitial pneumonia, tuberculosis, or sequelae of tuberculosis

Design outcomes

Primary

Measure	Time frame
FEV1	—

Secondary

Measure	Time frame
AUC24h of FEV1	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026